Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Magenta Therapeutics Presents New Preclinical Data on MGTA-145 Stem Cell Mobilization Product Candidate

Magenta Therapeutics, Inc (MGTA)  More Company Research Source: Business Wire
Last magenta therapeutics, inc earnings: 11/13 08:00 am Check Earnings Report
PDF A single dose of MGTA-145 mobilized large numbers of hematopoietic stem cells in hours that engrafted robustly in primates MGTA-145-mobilized cells blocked graft-vs.-host disease (GvHD) in preclinical models MGTA-145 to enter the clinic in the first half of 2019 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of bone marrow transplant to more patients, today announced that the Company highlighted new preclinical research on its MGTA-145 product candidate for stem cell mobilization in an oral presentation at the 60th annual meeting of the American Society of Hematology (ASH). MGTA-145 is being developed as a first-line agent to enable single-day mobilization of high numbers of hematopoietic stem cells for bone marrow transplant. “ [Read more]
Impact snapshot Event time: MGTA
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
MGTA alerts
from News Quantified
Opt-in for
MGTA alerts

from News Quantified
Opt-in for
MGTA alerts

from News Quantified